Most sickle cell disease patients who received the gene-editing therapy Casgevy have been free from vaso-occlusive crises for ...
Invisible complications of sickle cell disease can result in a lack of understanding and proper care, says columnist.
The majority of SCD patients given Lyfgenia in clinical trials remained free of vaso-occlusive events (VOEs) following ...
Kanglin Biotechnology has raised $20 million in financing to advance the development of sickle cell gene therapy KL003.
Columnist Sylvia Amuta works to manage her anxiety after noticing that her own stress has a negative impact on her cousin ...
Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...
Blood transfusions play a critical role in the management of sickle cell disease. They can help prevent and manage various complications as well as reduce disease severity. This lifesaving ...
Digital cognitive behavioral therapy was as effective as pain education at easing sickle cell pain, a study reported.